Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Fujitsu begins two-year medical AI research project

Partners with Kyoto University on R&D-focused work

Artificial intelligence AI pharma healthcare

Japanese IT company Fujitsu is collaborating with Kyoto University on a two-year project to investigate the use of artificial intelligence in medicine.

The partners are focused on AI’s possibilities in accelerating the research and development of next-generation medicine, such as new approaches to diagnostics and drug discovery.

The work will be run from the newly-established Department of Medical Intelligent Systems within Kyoto University.

The medical information put to use will include cancer patient data and patient data from electronic medical records collected by Kyoto University Hospital.

The firms say that existing AI technology has yet to adequately integrated the huge volumes of data from sources such as electronic medical records, medical journals and genomic data.

“To put this data to use, it has become essential to develop AI for medicine through the close collaboration of researchers with a high degree of knowledge of the medical field with AI researchers and engineers,” Fujitsu said in a statement.

Meanwhile, last year saw an uptick in life sciences interest in applying AI to drug research, with the likes of Scotland’s Exscientia scoring deals with GSK, Evotec and Sanofi, and Lundbeck signing up with IBM Watson Health.

1st February 2018

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics